The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of a phase I “RadVax” trial of hypofractionated radiation combined with pembrolizumab in patients with metastatic solid tumors.
 
John Nicholas Lukens
No Relationships to Disclose
 
Rosemarie Mick
Stock and Other Ownership Interests - Editas Medicine
 
Alexander Chan Chi Huang
Consulting or Advisory Role - Immunai
 
Nicholas Han
No Relationships to Disclose
 
Michael Farwell
Consulting or Advisory Role - ImaginAb
Research Funding - Bristol-Myers Squibb; Carisma Therapeutics; ImaginAb; Merck
 
Tara C. Mitchell
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; OncoSec
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; Merck
 
Ravi K. Amaravadi
Stock and Other Ownership Interests - Pinpoint Therapeutics
Honoraria - Deciphera
Consulting or Advisory Role - Immunaccel; Sprint Bioscience
Research Funding - Bristol-Myers Squibb; Novartis
Patents, Royalties, Other Intellectual Property - Pinpoint Therapeutics
 
Lynn Mara Schuchter
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck (Inst)
 
Abigail T. Berman
Honoraria - Imedex; Varian Medical Systems
Consulting or Advisory Role - AstraZeneca
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Varian Medical Systems
 
Mark H. O'Hara
Consulting or Advisory Role - Geneos; Natera
Research Funding - Arcus Biosciences; Bristol-Myers Squibb; Celldex; Lilly; Natera; Parker Institute for Cancer Immunotherapy
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Alisha Maity
No Relationships to Disclose
 
David Miller
No Relationships to Disclose
 
Andy Minn
Stock and Other Ownership Interests - Healthcare ETFs; Merck
Honoraria - H3 Biomedicine; Takeda
Consulting or Advisory Role - H3 Biomedicine; Takeda
Research Funding - Merck
 
Robert H. Vonderheide
Patents, Royalties, Other Intellectual Property - Inventor on a licensed patient regarding cancer vaccine antigens; Receives royalties from Children’s Hospital Boston for a licensed research-only monoclonal antibody
 
E. John Wherry
Stock and Other Ownership Interests - Surface Oncology
Research Funding - Celgene/Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Patent on the PD-1 pathway
Other Relationship - Surface Oncology
 
Amit Maity
Research Funding - Merck (Inst)